Spin and bias in published studies of breast cancer trials
Spin and bias exist in a high proportion of published studies of the outcomes and adverse side-effects of phase III clinical trials of breast cancer treatments, according to… read more.
Spin and bias exist in a high proportion of published studies of the outcomes and adverse side-effects of phase III clinical trials of breast cancer treatments, according to… read more.
Yet, researchers say lung cancer tests needed when making COPD diagnosis.
Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Haematology (ASH) signal an important step forward… read more.
Therapy may be new option for hard-to-treat blood cancer.
Proof-of-concept animal study selected as one of the best presentations at 54th American Society of Hematology Annual Meeting and Exposition.
Data demonstrate superior patient outcomes with B-R in first-line treatment of iNHL and MCL, compared with current standard of care.
Five additional studies presented at the 2012 Quality Care Symposium provided insight on how oncology practices can improve the quality of care they provide.
A new analysis has found that loading up on snack foods may increase cancer risk in individuals with an inborn susceptibility to colorectal and other cancers.
Unprecedented genomic sequencing of 14 metastatic TNBC patients yields potential drug targets
Researchers at Case Western Reserve University School of Medicine have identified a molecule linked to more aggressive forms of breast cancer – a discovery that could point the… read more.
There is no difference between proton radiotherapy (PRT) and intensity-modulated radiotherapy (IMRT) when comparing the toxicity among patients with prostate cancer at 12 months post-treatment according to a… read more.
Research presented at the American Society for Cell Biology (ASCB) annual meeting, 15-19 December 2012, San Francisco.
Advertisment